[1] EL-SAYED AAF.Preeclampsia:a review of the pathogenesis and possible management strategies based on its pathophysiological derangements[J].Taiwan J Obstet Gynecol, 2017, 56(5):593. doi: 10.1016/j.tjog.2017.08.004
[2] RAMOS JGL, SASS N, COSTA SHM.Preeclampsia[J].Rev Bras Ginecol Obstet, 2017, 39(9):496. doi: 10.1055/s-0037-1604471
[3] 郑丽婷, 夏俊霞.子痫前期发病机制分子生物学研究最新进展[J/CD].心电图杂志(电子版), 2019, 8(1):200.
[4] 史丹丹, 王勇, 郭君君, 等.子痫前期病人氧化应激、炎性反应及血管内皮损伤的临床研究[J].解放军医药杂志, 2018, 30(1):60. doi: 10.3969/j.issn.2095-140X.2018.01.016
[5] 谢幸, 荀文丽, 林仲秋, 等.妇产科学[M].8版.北京:人民卫生出版社, 2013:64.
[6] 朱君花, 雷侠.高风险子痫前期孕妇妊娠期高血压疾病影响因素的临床研究[J].中国实验诊断学, 2017, 21(2):250.
[7] HOLME AM, ROLAND MC, HENRIKSEN T, et al.In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies[J].Am J Obstet Gynecol, 2016, 215(6):782.
[8] FREITAS NA, SANTIAGO LTC, KUROKAWA CS, et al.Effect of preeclampsia on human milk cytokine levels[J].J Matern Fetal Neonatal Med, 2019, 32(13):2209. doi: 10.1080/14767058.2018.1429395
[9] CORNELIUS DC, COTTRELL J, AMARAL LM, et al.Inflammatory mediators:a causal link to hypertension during preeclampsia[J].Br J Pharmacol, 2019, 176(12):1914. doi: 10.1111/bph.14466
[10] TARAVATI A, TOHIDI F.Comprehensive analysis of oxidative stress markers and antioxidants status in preeclampsia[J].Taiwan J Obstet Gynecol, 2018, 57(6):779. doi: 10.1016/j.tjog.2018.10.002
[11] FERGUSON KK, MEEKER JD, MCELRATH TF, et al.Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies[J].Am J Obstet Gynecol, 2017, 216(5):527.
[12] RAIO L, BERSINGER NA, MALEK A, et al.Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia:a pilot study[J].J Hypertens, 2019, 37(5):1012. doi: 10.1097/HJH.0000000000002003
[13] 高翠红.应用Logistic回归分析炎性因子与子痫前期孕妇病情的相关性[J].中国免疫学杂志, 2019, 35(8):986. doi: 10.3969/j.issn.1000-484X.2019.08.019
[14] 吕艳关, 王丽, 赵玉杰.子痫前期病人血清PCT, HSP90及hs-CRP检测的临床意义[J].现代检验医学杂志, 2018, 33(4):83 doi: 10.3969/j.issn.1671-7414.2018.04.022
[15] 谢永玉.IL-21、IL-6、IL-16与脐动脉血流参数(S/D、RI、PI)对子痫前期的预测价值[D].南昌: 南昌大学, 2018.
[16] 马方玉, 岳莹, 谢倩, 等.中间型单核细胞在妊娠妇女子痫前期病情过程中的变化及临床意义[J].重庆医科大学学报, 2018, 43(9):1221.
[17] 廖丹.妊娠糖尿病合并妊高征病人hs-CRP、IL-6、TNF-α检测的临床意义[J].海南医学院学报, 2013, 19(12):1726.
[18] RAIO L, BERSINGER NA, MALEK A.et al.Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia:a pilot study[J].J Hypertens, 2019, 37(5):1012. doi: 10.1097/HJH.0000000000002003
[19] BLACK KD, HOROWITZ JA.Inflammatory markers and preeclampsia:a systematic review[J].Nurs Res, 2018, 67(3):242. doi: 10.1097/NNR.0000000000000285
[20] 徐宝兰, 张瑞珍.妊娠高血压综合征病人IL-6、TNF-α与hs-CRP水平分析[J].现代医药卫生, 2006(22):3434. doi: 10.3969/j.issn.1009-5519.2006.22.031
[21] GUERBY P, VIDAL F, GAROBY-SALOM S, et al.Oxidative stress and preeclampsia:a review[J].Gynecol Obstet Fertil, 2015, 43(11):751. doi: 10.1016/j.gyobfe.2015.09.011
[22] TAYSI S, TASCAN AS, UGUR MG, et al.Radicals, oxidative/nitrosative stress and preeclampsia[J].Mini Rev Med Chem, 2019, 19(3):178. doi: 10.2174/1389557518666181015151350
[23] 徐钦.孕妇血清、胎盘组织中Shh表达变化及滋养细胞氧化应激损伤、凋亡和子痫前期发病关系[D].福州: 福建医科大学, 2014.
[24] 李书平.8-isoprostane、ROS与子痫前期进展的相关性探讨[D].苏州: 苏州大学, 2013.
[25] 谢晓芳, 宋成凤.子痫前期病人oxLDL、8-isoprostane、MDA和MIF的检测及意义[J].南昌大学学报(医学版), 2016, 56(4):26.
[26] 欧阳艳琼.氧化应激和炎症反应在子痫前期中的作用及其相互关系的研究[D].武汉: 华中科技大学, 2007.
[27] MA Y, YE Y, ZHANG J, et al.Immune imbalance is associated with the development of preeclampsia[J].Medicine (Baltimore), 2019, 98(14):e15080. doi: 10.1097/MD.0000000000015080
[28] 李书平, 蒋学莲.炎症反应与子痫前期进展的临床相关性[J].实用临床医药杂志, 2014, 18(7):147.